Digital grain: America allows the use of the first digital pill in the world! So what is this pill?
Digital grain: America allows the use of the first digital pill in the world! So what is this pill?
Some drug companies have finally been able, after many years of research, to supply small pills with small sensors designed to monitor patients' adherence to their medications regularly, while these pills are expected to open up new drugs to treat other diseases.
The US Food and Drug Administration (FDA) has announced that it has allowed the use of the world's first "digital grain" with a small sensor sensor designed to monitor patients' adherence to their medications, specifically those suffering from mental illness.
The administration explained that the new pill, called Abiliti Meset, tells doctors or relatives of the patient if he has taken the medication regularly and correctly and on time, through a sensor built into this very small pill, where it communicates with a medical adhesive developed by the patient and activates after reaching Stomach and exposed to the impact of acids.
The Department of Medicine and Food explained that this pill is equipped with a small band attached to a medical patch placed on the patient's chest, so that the drug data is then transferred to a smart application that allows the doctor and nurse and friends or relatives of the patient to monitor the status of the drug, although the instructions approved by their mobile devices, The use of Abiliti Meset to treat psychopaths suffering from schizophrenia, bipolar disorder and depression.
It is noted that this digital pill is produced jointly by Japanese pharmaceutical company Utsuka and Proteus Digital Medicine. The IMS estimates that the misuse of drugs has cost the US healthcare sector more than $ 200 billion in 2012, Virg. "
"The digital grain has the potential to improve public health, but it can eliminate confidence if it is used incorrectly," said Amit Sarpatatwari, a professor at Harvard Medical School in an interview with The New York Times.